In the clinic for April 17, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Argenx, Arrivo, Astrazeneca, Atossa, Compass, Corcept, Edgewise, Ferring, Imugene, India Globalization Capital, Intra-Cellular Therapies, MRM Health, …